Avestar Capital’s Prestige Consumer Healthcare PBH Stock Holding History

Avestar Capital’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-240	Closed	-$7K	–	951
2018 Q4	$7K	Hold	240	–	–	﹤0.01%	492
2018 Q3	$9K	Hold	240	–	–	0.01%	482
2018 Q2	$9K	Hold	240	–	–	0.01%	483
2018 Q1	$8K	Buy	240 +145	+153%	+$5.56K	0.01%	468
2017 Q4	$4K	Buy	+95	New	+$4.33K	﹤0.01%	583

Other funds holding PBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Avestar Capital's PBH Position: Q1 2019 in Review

Avestar Capital sold out of Prestige Consumer Healthcare (PBH) in Q1 2019, closing a stake of 240 shares — an estimated $7K sold.

Avestar Capital first reported a position in PBH in Q4 2017 and held it in 5 quarters. The position peaked at $9K in Q3 2018. 221 funds tracked by Wall St. Rank hold PBH as of Q1 2019.

Avestar Capital reported no remaining Prestige Consumer Healthcare position as of Q1 2019 after selling out during the quarter.
Avestar Capital sold 240 Prestige Consumer Healthcare shares in Q1 2019, an estimated $7K.
Avestar Capital first reported a position in Prestige Consumer Healthcare in Q4 2017 and held it in 5 quarters.
Avestar Capital's Prestige Consumer Healthcare position peaked at $9K in Q3 2018.
221 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2019.

Based on Avestar Capital's 13F filing for Q1 2019, filed 9 May 2019.